Justin M. Balko, Pharm.D., Ph.D. is an Associate Professor of Medicine, Cancer Biology and Pathology, Microbiology and Immunology. He received his Pharm.D. from State University of New York at Buffalo and his Ph.D. from the University of Kentucky, Department of Pharmaceutical Sciences. Balko's laboratory is focused on improving treatment outcomes in breast cancer (particularly triple-negative breast cancer) as well as in other solid tumors. To accomplish this, they integrate data from genomic and molecular profiling studies with molecular biology and signal transduction methodologies to translationally identify altered pathways in cancer, the functional consequences of these alterations, and ways to directly target them in patients to improve clinical outcomes and survival. These efforts span in silico (publically available databases), in vitro (cell culture), in vivo (mouse and human clinical studies) and in situ (histology) methods. The lab has a strong interest in the intersection between new immunotherapies and tumor cell signaling pathways.... Click Dr. Balko's photo to continue reading.